-+ 0.00%
-+ 0.00%
-+ 0.00%

PureTech Health Announces Positive Phase 2b Extension Data for Deupirfenidone in IPF; Phase 3 Trial Design Update Expected Q4 2025

Reuters·09/29/2025 06:02:59

Please log in to view news